← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Pepgen Corporation
Alameda, CA
$2,193,838
Total funding
5
Grants
Funding mix
By agency
NIH$2,193,838 · 5
By mechanism
R44$1,109,735 · 1
R43$1,084,103 · 4
Investigators at Pepgen Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Non-toxic Human Interferon-Alpha Analog$555,265
R44 · FY2004 · AI
Non-toxic Human Interferon-Alpha Analog$554,470
R44 · FY2003 · AI
Oral IFN-tau treatment in RRMS patients$406,236
R43 · FY2004 · AI
Oral IFN-tau treatment in RRMS patients$326,484
R43 · FY2005 · AI
Oral Interferon Treatment in collagen induced arthritis$140,983
R43 · FY2003 · AR
IFN-tau treatment in mice infected with cowpox virus$110,400
R43 · FY2004 · AI
Non-toxic Human Interferon-Alpha Analog$100,000
R43 · FY2002 · AI